{
  "id": "PREVAIL_Model_guideline.v1",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2020-11-24",
      "name": "Maryam Razavi",
      "organisation": "CambioCDS",
      "email": "maryam.razavi@cambio.se"
    },
    "lifecycle_state": "Author draft",
    "details": {
      "en": {
        "id": "en",
        "purpose": "To predict overall survival in chemotherapy-naive patients with metastatic castration-resistant prostate cancer.",
        "keywords": [
          "Prostate",
          "Cancer",
          "chemotherapy",
          " castration-resistant"
        ],
        "use": "Note: This calculator has not been externally validated.\n\nVariables and points are as follows: \n- Treatment with enzalutamide planned: Yes=0, No=1\n- Current PSA value, ng/mL: Continuous\n- Time since diagnosis, months: Continuous\n- Albumin, g/dL: Continuous\n- Hemoglobin, g/dL: Continuous\n- Neutrophil to lymphocyte ratio (neutrophil number divided by lymphocyte number) <2.5: Yes=0, No=1\n- LDH below upper limit of normal: Yes=0, No=1\n- Pain 0-1 (on a scale of 0-10, 10 being the worst pain imaginable, highest pain rating in last 24 hrs): Yes=0, No=1\n- <10 bone metastases on bone scan: Yes=0, No=1\n- Alkaline phosphatase less than upper limit of normal: Yes=0, No=1\n- Pattern of spread: No visceral liver metastases=0, Any visceral liver metastases=1\n\nFormula: \nTotal score = (treatment x 18.1376) + [(ln(PSA) + 2.3026) x 9.52244917] + [(275.9 - time) x 0.1543483] + [(4.9 - albumin) x 16.0447656796] + [(16.8 - hemoglobin) x 7.7519235] + (neutrophil x 17.613) + (LDH x 19.00635) + (pain x 12.2248) + (bone x 17.7533) + (alkaline x 10.9685) + (spread x 32.991)",
        "copyright": "CambioCDS"
      }
    },
    "other_details": {
      "references": "1. Armstrong AJ, Lin P, Higano CS, et al. Development and validation of a prognostic model for overall survival in chemotherapy-naïve men with metastatic castration-resistant prostate cancer. Ann Oncol. 2018;29(11):2200-2207.\n2. Armstrong AJ, Lin P, Tombal B, et al. Five-year Survival Prediction and Safety Outcomes with Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer from the PREVAIL Trial. Eur Urol. 2020;9(6)."
    }
  },
  "definition": {
    "data_bindings": {
      "gt0002": {
        "id": "gt0002",
        "model_id": "openEHR-EHR-OBSERVATION.prevail_model.v0",
        "template_id": "openEHR-EHR-OBSERVATION.prevail_model.v0",
        "type": "INPUT",
        "elements": {
          "gt0003": {
            "id": "gt0003",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0004]"
          }
        }
      },
      "gt0004": {
        "id": "gt0004",
        "model_id": "openEHR-EHR-OBSERVATION.lab_test_psa.v1",
        "template_id": "openEHR-EHR-OBSERVATION.lab_test_psa.v1",
        "type": "INPUT",
        "elements": {
          "gt0005": {
            "id": "gt0005",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0004]"
          }
        }
      },
      "gt0006": {
        "id": "gt0006",
        "model_id": "openEHR-EHR-OBSERVATION.prevail_model.v0",
        "template_id": "openEHR-EHR-OBSERVATION.prevail_model.v0",
        "type": "INPUT",
        "elements": {
          "gt0007": {
            "id": "gt0007",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0007]"
          }
        }
      },
      "gt0008": {
        "id": "gt0008",
        "model_id": "openEHR-EHR-OBSERVATION.laboratory_test_result-serum_albumin.v1",
        "template_id": "openEHR-EHR-OBSERVATION.laboratory_test_result-serum_albumin.v1",
        "type": "INPUT",
        "elements": {
          "gt0009": {
            "id": "gt0009",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0.121]"
          }
        }
      },
      "gt0010": {
        "id": "gt0010",
        "model_id": "openEHR-EHR-OBSERVATION.lab_test-full_blood_count.v1",
        "template_id": "openEHR-EHR-OBSERVATION.lab_test-full_blood_count.v1",
        "type": "INPUT",
        "elements": {
          "gt0011": {
            "id": "gt0011",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0078.4]"
          }
        }
      },
      "gt0012": {
        "id": "gt0012",
        "model_id": "openEHR-EHR-OBSERVATION.prevail_model.v0",
        "template_id": "openEHR-EHR-OBSERVATION.prevail_model.v0",
        "type": "INPUT",
        "elements": {
          "gt0013": {
            "id": "gt0013",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0008]"
          },
          "gt0014": {
            "id": "gt0014",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0011]"
          },
          "gt0015": {
            "id": "gt0015",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0014]"
          },
          "gt0016": {
            "id": "gt0016",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0017]"
          },
          "gt0017": {
            "id": "gt0017",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0020]"
          },
          "gt0018": {
            "id": "gt0018",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0023]"
          }
        }
      },
      "gt0019": {
        "id": "gt0019",
        "model_id": "openEHR-EHR-OBSERVATION.prevail_model.v0",
        "template_id": "openEHR-EHR-OBSERVATION.prevail_model.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0020": {
            "id": "gt0020",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0026]"
          }
        }
      }
    },
    "rules": {
      "gt0021": {
        "id": "gt0021",
        "priority": 1,
        "when": [
          "$gt0003|Treatment with enzalutamide planned|!=null",
          "$gt0005|PSA value|!=null",
          "$gt0007|Time since diagnosis|!=null",
          "$gt0009|Serum Albumin|!=null",
          "$gt0011|Hemoglobin|!=null",
          "$gt0009|Serum Albumin|.unit=='gm/dl'",
          "$gt0011|Hemoglobin|.unit=='gm/dl'",
          "$gt0013|Neutrophil to lymphocyte ratio <2.5|!=null",
          "$gt0014|LDH below upper limit of normal|!=null",
          "$gt0015|Pain 0-1|!=null",
          "$gt0016|<10 bone metastases on bone scan|!=null",
          "$gt0017|Alkaline phosphatase less than upper limit of normal|!=null",
          "$gt0018|Pattern of spread|!=null"
        ],
        "then": [
          "$gt0020|Total score|.magnitude=($gt0003.value*18.1376)+((log($gt0005.magnitude)+2.3026)*9.52244917)+((275.9-$gt0007.magnitude)*0.1543483)+((4.9-$gt0009.magnitude)*16.0447656796)+((16.8-$gt0011.magnitude)*7.7519235)+($gt0013.value*17.613)+($gt0014.value*19.00635)+($gt0015.value*12.2248)+($gt0016.value*17.7533)+($gt0017.value*10.9685)+($gt0018.value*32.991)",
          "$gt0020|Total score|.unit='1'"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "PREVAIL Model",
            "description": "PREVAIL Model for Prostate Cancer Survival"
          },
          "gt0003": {
            "id": "gt0003",
            "text": "Treatment with enzalutamide planned",
            "description": "*"
          },
          "gt0005": {
            "id": "gt0005",
            "text": "PSA value",
            "description": "Lab test result of prostate-specific antigen (PSA)"
          },
          "gt0007": {
            "id": "gt0007",
            "text": "Time since diagnosis",
            "description": "*"
          },
          "gt0009": {
            "id": "gt0009",
            "text": "Serum Albumin",
            "description": "Serum albumin level in this specimen."
          },
          "gt0011": {
            "id": "gt0011",
            "text": "Hemoglobin",
            "description": "The mass concentration of haemoglobin"
          },
          "gt0013": {
            "id": "gt0013",
            "text": "Neutrophil to lymphocyte ratio <2.5",
            "description": "Neutrophil number divided by lymphocyte number"
          },
          "gt0014": {
            "id": "gt0014",
            "text": "LDH below upper limit of normal",
            "description": "*"
          },
          "gt0015": {
            "id": "gt0015",
            "text": "Pain 0-1",
            "description": "On a scale of 0-10, 10 being the worst pain imaginable, highest pain rating in last 24 hrs"
          },
          "gt0016": {
            "id": "gt0016",
            "text": "<10 bone metastases on bone scan",
            "description": "*"
          },
          "gt0017": {
            "id": "gt0017",
            "text": "Alkaline phosphatase less than upper limit of normal",
            "description": "*"
          },
          "gt0018": {
            "id": "gt0018",
            "text": "Pattern of spread",
            "description": "*"
          },
          "gt0020": {
            "id": "gt0020",
            "text": "Total score",
            "description": "*"
          },
          "gt0021": {
            "id": "gt0021",
            "text": "Set Total score"
          }
        }
      }
    }
  }
}